Pangenomic Health Inc.
Pangenomic Health Inc. operates as a precision health company in Canada. The company offers Nara App, a telehealth mental health app that provides users with personalized information about non-pharmaceutical alternatives to address mental health concerns; and Mindleap, a telehealth platform, which provides various tools and resources to help individuals understand and improve their inner wellness… Read more
Pangenomic Health Inc. (LL3) - Total Assets
Latest total assets as of September 2025: €270.90K EUR
Based on the latest financial reports, Pangenomic Health Inc. (LL3) holds total assets worth €270.90K EUR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Pangenomic Health Inc. - Total Assets Trend (2021–2024)
This chart illustrates how Pangenomic Health Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Pangenomic Health Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Pangenomic Health Inc.'s total assets of €270.90K consist of 94.9% current assets and 5.1% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 3.3% |
| Accounts Receivable | €30.89K | 78.9% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how Pangenomic Health Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Pangenomic Health Inc.'s current assets represent 94.9% of total assets in 2024, an increase from 64.8% in 2021.
- Cash Position: Cash and equivalents constituted 3.3% of total assets in 2024, down from 52.3% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 32.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 78.9% of total assets.
Pangenomic Health Inc. Competitors by Total Assets
Key competitors of Pangenomic Health Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
UCrest Bhd
KLSE:0005
|
Malaysia | RM48.46 Million |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638
|
China | CN¥265.74 Million |
|
BIT Computer Co. Ltd
KQ:032850
|
Korea | ₩82.38 Billion |
|
ezCaretech Co. LTD
KQ:099750
|
Korea | ₩56.71 Billion |
|
SyntekaBio Inc
KQ:226330
|
Korea | ₩33.49 Billion |
|
Carelabs Co.Ltd
KQ:263700
|
Korea | ₩105.15 Billion |
|
Shanghai Kingstar Winning Software
SHE:300253
|
China | CN¥8.35 Billion |
|
Longmaster Information Tech
SHE:300288
|
China | CN¥1.33 Billion |
Pangenomic Health Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Pangenomic Health Inc. generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Pangenomic Health Inc. is currently not profitable relative to its asset base.
Pangenomic Health Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.13 | 0.04 | 0.04 |
| Quick Ratio | 0.13 | 0.04 | 0.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-1.78 Million | € -1.65 Million | € -1.65 Million |
Pangenomic Health Inc. - Advanced Valuation Insights
This section examines the relationship between Pangenomic Health Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 122.97 |
| Asset Growth Rate (YoY) | -45.2% |
| Total Assets | €39.16K |
| Market Capitalization | $4.82 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Pangenomic Health Inc.'s assets at a significant premium ( 122.97x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Pangenomic Health Inc.'s assets decreased by 45.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Pangenomic Health Inc. (2021–2024)
The table below shows the annual total assets of Pangenomic Health Inc. from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €39.16K | -45.21% |
| 2023-12-31 | €71.48K | -85.82% |
| 2022-12-31 | €504.14K | -80.44% |
| 2021-12-31 | €2.58 Million | -- |